Physician

Ghada Mahmood Kunter, MD

According to 2025 Medicare claims, Ghada Kunter, MD (NPI: 1851566202) practices hematology/oncology in the Atlanta-Sandy Springs-Roswell, GA market, with the plurality of this provider's patient population coming from Pickens, GA. This provider's primary affiliated billing organization is WELLSTAR MEDICAL GROUP, LLC (NPI: 1275992240; TIN: 273818647) and primary practice location at 30143-4910. Kunter is affiliated with the Mission Health Partners, LLC (ACO ID: A2591) and WellStar Clinical Partners Medicare ACO, LLC (ACO ID: A4803), participating under the MSSP model.

Kunter's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 599 traditional Medicare patients, billed 248,641 HCPCS/CPT codes, and received $2,722,521 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,677 prescription claims across 320 beneficiaries totaling $921,544 in drug costs, led by Imbruvica (Ibrutinib). 2023 DME data shows 23 claims. Open Payments data shows 127 records totaling $6,218. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,997 to $2,722,521. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	52	88	$5,997
2016	276	895	$58,566
2017	318	1,038	$54,821
2018	339	68,969	$772,664
2019	482	126,940	$1,451,226
2020	359	152,943	$1,595,023
2021	398	153,014	$1,240,760
2022	420	153,218	$1,588,706
2023	516	257,374	$2,523,342
2024	599	248,641	$2,722,521

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	18	37	$15,587
2016	95	506	$182,953
2017	103	734	$266,073
2018	147	713	$968,953
2019	183	993	$2,087,054
2020	217	1,479	$2,771,083
2021	236	1,515	$2,564,380
2022	215	1,242	$1,845,896
2023	260	1,422	$1,343,308
2024	320	1,677	$921,544

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	30	$1,929
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	23	$3,853
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	105	168	$132
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	88	88	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	460	1,224	$90
36415	Insertion of needle into vein for collection of blood sample	337	937	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	370	995	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	13	364	$212,772
Eliquis	Apixaban	96	3,900	$73,382
Xarelto	Rivaroxaban	16	840	$15,561
Oxycontin	Oxycodone Hcl	11	330	$6,454
Anastrozole	Anastrozole	180	12,852	$3,661

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	127	$6,218	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ghada Mahmood Kunter, MD?

Tedicare shows public-source Medicare data for Ghada Mahmood Kunter, MD (NPI 1851566202), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ghada Mahmood Kunter, MD have ACO affiliation data?

Ghada Mahmood Kunter, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591) and WellStar Clinical Partners Medicare ACO, LLC (MSSP, ACO ID A4803).

What billing organization is linked to Ghada Mahmood Kunter, MD?

Ghada Mahmood Kunter, MD is linked to WELLSTAR MEDICAL GROUP, LLC (billing NPI 1275992240) in the available physician profile data.

Does Ghada Mahmood Kunter, MD have Open Payments data?

Ghada Mahmood Kunter, MD has 127 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.